AllTrials: will it catch on in the US?
This article was originally published in Scrip
Executive Summary
News that the AllTrials campaign has been launched in the US will be welcomed by transparency advocates. But it will be viewed with great disquiet by those in industry and elsewhere who are open to a degree of greater clinical trial disclosure but draw the line at releasing patient-level data.